Jang CY, et al. - Authors estimated 162 subjects of age ≥70 years were evaluated to investigate the consequence of continuous perioperative antiplatelet medication on the outcomes following cephalomedullary nailing (CMN) in subjects with a proximal femur fracture. They noted a higher incidence of concomitant cardiovascular and endocrinologic diseases. Such candidates were given a perioperative transfusion and were admitted to the intensive care unit (ICU) postoperatively. They suggested CMN without delay in elder cases with proximal femoral fracture receiving antiplatelet therapy earlier to admission without discontinuing antiplatelets. They also found safe in subjects who were not on antiplatelet medication. Although, caution was recommended with respect to transfusions and ICU care after surgery.